Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 6/20 | 0.52 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL5066905 | 1.00 | RARB (0.53) | RARBLTA4HTSHRTP53FAAH | |
| Methacrylic Acid SCHEMBL17509594 | 1.00 | RARB (0.53) | RARBLTA4HTSHRTP53FAAH | |
| Methacrylic Acid SCHEMBL28133150 | 0.93 | LTA4H (0.60) | RARBLTA4HTSHRTP53FAAH | |
| Acetic Acid SCHEMBL11881776 | 0.91 | RARB (0.58) | RARBLTA4HTSHRTP53FAAH | |
| SCHEMBL11252092 | 0.87 | LTA4H (0.68) | RARBLTA4HTSHRTP53FAAH | |
| SCHEMBL11408805 | 0.87 | LTA4H (0.68) | RARBLTA4HTSHRTP53FAAH | |
| SCHEMBL1408157 | 0.87 | LTA4H (0.68) | RARBLTA4HTSHRTP53FAAH | |
| SCHEMBL148235 | 0.87 | LTA4H (0.68) | RARBLTA4HTSHRTP53FAAH | |
| SCHEMBL2052458 | 0.87 | LTA4H (0.68) | RARBLTA4HTSHRTP53FAAH | |
| SCHEMBL11084816 | 0.87 | LTA4H (0.68) | RARBLTA4HTSHRTP53FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109689815-B | Heat-curable conductive adhesive | 三键有限公司 | 2022-06-14 | — | — | CN | claimed |
| US-20020042112-A1 | DNA DIAGNOSTICS BASED ON MASS SPECTROMETRY | SEQUENOM, INC. | 2002-04-11 | — | — | US | claimed |
| EP-0492509-B1 | Vinyl polymer having (meth)acryloyl groups on the side chains and method for preparing same | KYOEISHA CHEMICAL CO LTD (JP) | 1995-09-20 | — | — | EP | claimed |
| US-10195133-B2 | Photocurable composition for nail or artificial nail | THREE BOND CO., LTD. | 2019-02-05 | — | — | US | disclosed |
| US-20170157022-A1 | PHOTOCURABLE COMPOSITION FOR NAIL OR ARTIFICIAL NAIL | THREE BOND CO., LTD. (JP) | 2017-06-08 | — | — | US | disclosed |
| US-9102840-B2 | Polyurethane resin addition pigment, process for producing polyurethane resin addition pigment, pigment dispersion composition, and jet printing ink composition | TOKAI CARBON CO., LTD. (JP) | 2015-08-11 | — | — | US | disclosed |
| US-20130217826-A1 | POLYURETHANE RESIN ADDITION PIGMENT, PROCESS FOR PRODUCING POLYURETHANE RESIN ADDITION PIGMENT, PIGMENT DISPERSION COMPOSITION, AND JET PRINTING INK COMPOSITION | TOKAI CARBON CO., LTD. (JP) | 2013-08-22 | — | — | US | disclosed |
| US-8038832-B2 | Curable composition and sealing method | THREE BOND CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20090025870-A1 | CURABLE COMPOSITION AND SEALING METHOD | THREE BOND CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1460083-A1 | High density immobilization of nucleic acids | SEQUENOM, INC. (US) | 2004-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042112-A1 | DNA DIAGNOSTICS BASED ON MASS SPECTROMETRY | DNA2, DDB1, DNMT3A | RARB 4139/4885LTA4H 2565/4885TSHR 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.